USE OF AlphaCP1, AlphaCP2, AND HUR FOR MODULATING GENE EXPRESSION AND INDUCING AN- GIOGENESIS

Details for Australian Patent Application No. 2002322911 (hide)

Owner ANGIOGENE INC.

Inventors GUY, Louis-Georges

Pub. Number AU-A-2002322911

PCT Number PCT/CA02/01275

PCT Pub. Number WO2003/016343

Priority 60/312,397 16.08.01 US

Filing date 16 August 2002

Wipo publication date 3 March 2003

International Classifications

C07K 014/47 Peptides having more than 20 amino acids

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/312,397 16.08.01 US

29 May 2003 Application Open to Public Inspection

  Published as AU-A-2002322911

6 May 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002322912-ZERO LENGTH CROSS-LINKING OF PROTEINS AND RELATED COMPOUNDS

2002322910-METHOD AND SYSTEM FOR FINGERPRINT ENCODING AND AUTHENTICATION